Carlo Salvarani Selected Research

tocilizumab (atlizumab)

11/2022	Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients.
1/2022	New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.
1/2022	Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis.
10/2021	Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
9/2021	Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia.
1/2021	Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
1/2021	Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
1/2021	Aortic dilatation in a patient with Takayasu arteritis treated with tocilizumab.
11/2020	Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia.
11/2020	TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlo Salvarani Research Topics

Disease

40	Giant Cell Arteritis (Horton Disease) 08/2022 - 11/2002
32	Vasculitis (Vasculitides) 01/2022 - 04/2004
23	Rheumatoid Arthritis 04/2022 - 06/2006
22	Psoriatic Arthritis 10/2022 - 08/2003
17	Inflammation (Inflammations) 01/2022 - 02/2008
16	COVID-19 10/2022 - 01/2020
15	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 10/2015 - 04/2002
14	Uveitis 10/2022 - 01/2006
14	Ankylosing Spondylitis 01/2022 - 03/2002
12	Takayasu Arteritis (Arteritis, Takayasu's) 11/2022 - 10/2011
12	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2021 - 01/2020
11	Infections 04/2022 - 05/2007
11	Axial Spondyloarthritis 01/2022 - 07/2014
10	Pneumonia (Pneumonitis) 10/2022 - 08/2020
10	Retroperitoneal Fibrosis 03/2017 - 01/2006
9	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 08/2009
8	Arthritis (Polyarthritis) 02/2022 - 01/2006
8	Pain (Aches) 01/2022 - 03/2002
8	Central Nervous System Vasculitis 04/2020 - 11/2007
7	Necrosis 01/2020 - 01/2008
7	Cerebral Infarction 01/2019 - 11/2007
6	Rheumatic Diseases (Rheumatism) 02/2022 - 12/2007
6	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2021 - 04/2008
5	Headache (Headaches) 01/2022 - 06/2009
5	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022 - 05/2014
5	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 10/2011
4	Systemic Scleroderma (Systemic Sclerosis) 06/2022 - 01/2018
4	Neoplasms (Cancer) 04/2022 - 06/2009
4	Fatigue 01/2022 - 11/2017
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 07/2012
4	Idiopathic Pulmonary Fibrosis 06/2021 - 01/2020
4	Connective Tissue Diseases (Connective Tissue Disease) 03/2021 - 02/2020
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2018
4	Autoimmune Diseases (Autoimmune Disease) 09/2020 - 01/2006
4	Sacroiliitis 01/2019 - 03/2002
4	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018 - 04/2004
3	Tuberculosis (Tuberculoses) 04/2022 - 08/2016
3	Non-Radiographic Axial Spondyloarthritis 01/2022 - 02/2015
3	Fever (Fevers) 01/2022 - 05/2016
3	Proteinuria 11/2021 - 01/2018
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 05/2021 - 01/2018
3	Injection Site Reaction 12/2020 - 06/2009
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2015 - 10/2013
3	Cognitive Dysfunction 05/2015 - 11/2007
3	Shoulder Pain 04/2012 - 03/2011
3	Synovitis 02/2012 - 12/2009
3	Body Weight (Weight, Body) 01/2012 - 05/2007
3	Spondylarthropathies 09/2011 - 05/2009
2	Disease Progression 11/2022 - 01/2021
2	Lymphoma (Lymphomas) 10/2022 - 01/2018
2	Skin Ulcer 06/2022 - 04/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022 - 06/2009

Drug/Important Bio-Agent (IBA)

29	tocilizumab (atlizumab)FDA Link 11/2022 - 10/2011
25	GlucocorticoidsIBA 10/2022 - 04/2002
22	Biological ProductsIBA 04/2022 - 05/2007
17	Prednisone (Sone)FDA LinkGeneric 01/2022 - 10/2004
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2020 - 05/2003
14	Etanercept (Enbrel)FDA Link 01/2022 - 01/2006
13	Infliximab (Remicade)FDA Link 02/2022 - 04/2003
12	Antirheumatic Agents (DMARD)IBA 04/2022 - 08/2003
12	SteroidsIBA 01/2022 - 04/2003
12	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 04/2008
11	C-Reactive ProteinIBA 11/2022 - 02/2006
11	Rituximab (Mabthera)FDA Link 08/2022 - 04/2014
11	Interleukin-6 (Interleukin 6)IBA 11/2020 - 04/2002
10	Adalimumab (Humira)FDA Link 04/2022 - 07/2012
9	Pharmaceutical PreparationsIBA 01/2022 - 02/2015
9	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2020 - 04/2002
8	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2021 - 04/2003
7	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2008
7	CytokinesIBA 10/2021 - 04/2004
7	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 10/2004
7	GadoliniumIBA 01/2019 - 11/2007
6	AntibodiesIBA 12/2021 - 07/2014
5	Peptides (Polypeptides)IBA 01/2019 - 01/2006
5	Immunosuppressive Agents (Immunosuppressants)IBA 08/2018 - 01/2006
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2017 - 08/2008
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2021 - 02/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2020 - 10/2003
4	Amyloid (Amyloid Fibrils)IBA 01/2019 - 03/2002
3	Methylprednisolone FDA LinkGeneric 10/2022 - 09/2021
3	Biosimilar PharmaceuticalsIBA 02/2022 - 01/2020
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 04/2005
3	ixekizumabIBA 11/2021 - 01/2019
3	belimumabIBA 11/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2012
3	Tumor Necrosis Factor InhibitorsIBA 06/2020 - 01/2016
3	golimumab FDA Link 01/2020 - 11/2017
3	InterleukinsIBA 01/2019 - 02/2013
3	Prostaglandins AIBA 01/2018 - 09/2009
3	Monoclonal AntibodiesIBA 01/2018 - 08/2003
3	Interleukin-33IBA 07/2017 - 02/2013
3	CCR5 Receptors (CCR5 Receptor)IBA 09/2013 - 06/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 09/2021
2	Interleukin-22 (IL-22)IBA 08/2022 - 01/2018
2	Creatine Kinase (Creatine Phosphokinase)IBA 04/2022 - 07/2012
2	upadacitinibIBA 04/2022 - 12/2021

Therapy/Procedure

63	Therapeutics 10/2022 - 04/2003
6	Biological Therapy 05/2021 - 05/2009
2	Drug Therapy (Chemotherapy) 10/2022 - 01/2022